Relapsed T cell Non-Hodgkin Lymphoma
Showing 9951 - 9975 of >10,000
Etiosarc: Environmental Aetiology of Sarcomas FromMulticenter
Recruiting
- Sarcoma
- +3 more
- Environmental, occupational and lifestyle-related exposures
-
Besançon, France
- +9 more
Aug 25, 2021
Early Detection of de Novo Cancer in Liver Transplant Recipients
Completed
- De Novo Cancer
- Liver Transplant Disorder
- (no location specified)
Aug 5, 2022
Preoperative BNP and MINS in AAA Open Repair
Active, not recruiting
- Myocardial Injury After Non-cardiac Surgery
- preoperative BNP value
-
Seoul, Korea, Republic ofGangnam severance Hospital
Oct 12, 2023
Stage III, NSCLC Trial in Chengdu (tislelizumab)
Active, not recruiting
- Stage III
- Non-small Cell Lung Cancer
-
Chengdu, Sichuan, ChinaUniversity
Apr 28, 2021
Ocrelizumab on Choroid Plexus Changes in Patients With PPMS
Not yet recruiting
- Primary Progressive Multiple Sclerosis
- Ocrelizumab
-
Buffalo, New YorkBuffalo Neuroimaging Analysis Center
Jul 26, 2023
Periodontal Inflammation Trial in Cairo (diode laser, non surgical scaling)
Recruiting
- Periodontal Inflammation
- diode laser
- non surgical scaling
-
Cairo, Nasrcity Nasr Street, Egypt
- +1 more
Nov 20, 2023
Exhaled Breath Particles in Lung Cancer
Recruiting
- Lung Cancer
- +3 more
- EBPcollected using the PExA device.
-
Lund, Skåne Län, SwedenSkåne University Hospital
May 24, 2022
Thin Endometrium, Intrauterine Adhesion Trial in Hangzhou (umbilical cord mesenchymal stem cells combined with collagen
Completed
- Thin Endometrium
- Intrauterine Adhesion
- umbilical cord mesenchymal stem cells combined with collagen scaffold
-
Hangzhou, ChinaSir Run Run Shaw hopital,School of medicine,Zhejiang University
Apr 10, 2021
Hepatocellular Carcinoma Trial in Villejuif (RAPID procedure)
Not yet recruiting
- Hepatocellular Carcinoma
- RAPID procedure
-
Villejuif, FranceAP-HP, Paul Brousse Hospital
Jul 24, 2023
Personalized Signature of Chronic Inflammation and Early Aging
Recruiting
- Male Infertility
- Collection of clinical and biological material
-
Milan, Lombardy, ItalyIRCCS Ospedale San Raffaele
Oct 9, 2023
Diabetic Foot, Diabetic Foot Ulcer, Foot Ulcer Trial in United States (Symphony™ plus Off-loading, Wound Dressing comprising of
Recruiting
- Diabetic Foot
- +3 more
- Symphony™ plus Off-loading
- Wound Dressing comprising of calcium alginate Fibracol
-
Los Angeles, California
- +5 more
Sep 13, 2023
Digestive System Malignant Solid Tumors Trial (ScTIL injection, ScTIL injection and B lymphocytes adjuvant)
Not yet recruiting
- Digestive System Malignant Solid Tumors
- ScTIL injection
- ScTIL injection and B lymphocytes adjuvant
- (no location specified)
Feb 7, 2023
Production of iPSC Derived RPE Cells for Transplantation in AMD
Completed
- Age Related Macular Degeneration (AMD)
- (no location specified)
Apr 4, 2022
Diabetes, Type 2 Trial (Telemonitoring 1, Telemonitoring 2)
Not yet recruiting
- Diabetes Mellitus, Type 2
- Telemonitoring 1
- Telemonitoring 2
- (no location specified)
Nov 14, 2023
AML, Adult, Minimal Residual Disease Trial in Guangzhou (chidamide and azacitidine)
Not yet recruiting
- AML, Adult
- Minimal Residual Disease
- chidamide and azacitidine
-
Guangzhou, Guangdong, ChinaGuangdong Provincial People's Hospital
Sep 27, 2023
Metastatic Non Small Cell Lung Cancer Trial in Italy (Tedopi, Nivolumab, Docetaxel)
Recruiting
- Metastatic Non Small Cell Lung Cancer
- Tedopi
- +2 more
-
Meldola, Forlì, Italy
- +11 more
Feb 9, 2022
Nipple Neurotization
Completed
- Breast Reconstruction
-
Taoyuan, TaiwanChangGungMH
Jun 7, 2023
Covid-related Pneumonia Trial (MesenCure, Placebo)
Not yet recruiting
- Covid-related Pneumonia
- MesenCure
- Placebo
- (no location specified)
Aug 9, 2022
Kidney Cancer Trial in Birmingham (Acarbose Tablets)
Not yet recruiting
- Kidney Cancer
- Acarbose Tablets
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Aug 2, 2022
NSCLC Trial (Recombinant anti-VEGFR2 fully human mAb (JY025))
Not yet recruiting
- NSCLC
- Recombinant anti-VEGFR2 fully human monoclonal antibody (JY025)
- (no location specified)
May 7, 2021
Relapsed/Refractory Mantle Cell Lymphoma Trial in Worldwide (Lenalidomide, Ibrutinib, Rituximab)
Completed
- Relapsed/Refractory Mantle Cell Lymphoma
- Lenalidomide
- +2 more
-
Copenhagen, Denmark
- +4 more
Apr 22, 2020
Cardiopulmonary Bypass Induced Red Blood Cell Lysis
Recruiting
- Cardiopulmonary Bypass
- +2 more
- Blood and urine collection
-
Baltimore, MarylandCenter for Blood Oxygen Transport and Hemostasis
Jun 29, 2022